Variables | Periodontitis group (n=47) | Non-periodontitis group (n=180) | P values |
Follow-up duration (months) | 16.9±10.3 | 19.1±15.0 | 0.349 |
MACE (%) | 40 (85.1) | 44 (24.6) | <0.001 |
Total death (%) | 1 (2.3) | 1 (0.6) | 0.356 |
Cardiac death (%) | 1 (2.3) | 1 (0.6) | |
Total thromboembolic events (%) | 14 (29.8) | 1 (0.6) | <0.001 |
CVA (new onset, %) | 12 (25.8) | 0 (0) | |
Peripheral thromboembolism (%) | 2 (4.0) | 1 (0.6) | |
Bleeding complications (%) | 3 (6.8) | 13 (7.3) | 1.000 |
Arrhythmic events (%) | 44 (93.6) | 31 (17.4) | <0.001 |
SVT including AF, AFL or ATach (%) | 44 (93.6) | 30 (16.9) | |
VPC or VTach (%) | 0 (0) | 1 (0.5) | |
Treatment of AF | |||
DC cardioversion for rhythm control (%) | 7 (14.5) | 18 (10.5) | 0.042 |
Values are mean ±SD (range).
AFL, atrial flutter; ATach, atrial tachycardia; CVA, cerebrovascular accidents; MACE, major adverse cardiac events; SVT, supraventricular tachycardia; VPC, ventricular premature complex; VTach, ventricular tachycardia.